Properties (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
genetic disorder
|
| gptkbp:advertising |
important for early detection
|
| gptkbp:associatedWith |
gptkb:hemangioblastomas
gptkb:pheochromocytomas renal cell carcinoma |
| gptkbp:causedBy |
tumors
|
| gptkbp:complications |
cancer
neurological issues organ dysfunction |
| gptkbp:demographics |
1 in 36,000
|
| gptkbp:diseaseResistance |
genetic testing
imaging studies clinical evaluation family history assessment |
| gptkbp:established |
Landmark_von_Hippel_and_Arvid_Lindau
|
| gptkbp:geneticDiversity |
recommended for families
VHL gene 3p25.3 |
| https://www.w3.org/2000/01/rdf-schema#label |
von Hippel-Lindau disease
|
| gptkbp:impact |
surgery
medication radiation therapy |
| gptkbp:inheritsFrom |
autosomal dominant inheritance
|
| gptkbp:introduced |
in 1894
|
| gptkbp:legalEvent |
normal with treatment
|
| gptkbp:manager |
multidisciplinary approach
|
| gptkbp:publications |
case studies
reviews patient information resources guidelines for management numerous scientific articles |
| gptkbp:relatedPatent |
neurofibromatosis type 2
tuberous sclerosis |
| gptkbp:research |
ongoing studies
for family members |
| gptkbp:researchFocus |
clinical trials
gene therapy targeted therapies |
| gptkbp:riskManagement |
family history
genetic mutations |
| gptkbp:screenings |
regular MRI scans
|
| gptkbp:supports |
patient advocacy groups
|
| gptkbp:symptoms |
dizziness
fatigue nausea abdominal pain vision problems high blood pressure headaches tinnitus |